Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Liposomal Bupivacaine Post Septorhinoplasty
Sponsor: Jessyka Lighthall
Summary
The objective of this study is to determine if there is a difference in post-operative pain after septorhinoplasty when long-acting liposomal bupivacaine is used for local anesthesia compared to other standard local anesthetic regimens.
Official title: The Efficacy of Liposomal Bupivacaine in the Management of Post-operative Pain Following Septorhinoplasty: A Single-blinded, Prospective Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2024-02-05
Completion Date
2027-07
Last Updated
2026-04-03
Healthy Volunteers
Yes
Conditions
Interventions
Liposomal Bupivacaine
Patients will receive post-operative liposomal bupivacaine (EXPAREL®) at the surgical site at the completion of their septorhinoplasty.
0.25% bupivacaine with 1:200,000 epinephrine
Non-liposomal encapsulated bupivacaine at the surgical site at the completion of septorhinoplasty.
Placebo - Saline solution
This group will receive a one-time 5 mL injection of saline post-operatively at the surgical site.
Locations (1)
Jessyka Lighthall
Hershey, Pennsylvania, United States